Citation: | XING Benyuan, DAI Xinyu, DING Hong, NIAN Fujia, PENG Gang, LI Yuntao. Correlation between inflammatory response and peripheral blood platelet-lymphocyte ratio and vitelliform degeneration in human carotid atherosclerotic plaques[J]. Chinese Journal of General Practice, 2023, 21(11): 1845-1848. doi: 10.16766/j.cnki.issn.1674-4152.003239 |
[1] |
WOLF D, LEY K. Immunity and inflammation in atherosclerosis[J]. Circ Res, 2019, 124(2): 315-327. doi: 10.1161/CIRCRESAHA.118.313591
|
[2] |
ZHU Y, XIAN X, WANG Z, et al. Research progress on the relationship between atherosclerosis and inflammation[J]. Biomolecules, 2018, 8(3): 80. doi: 10.3390/biom8030080
|
[3] |
管晶晶, 时鹏. 颈动脉粥样硬化斑块超声联合血脂指标对心血管疾病的预测价值评估[J]. 中华全科医学, 2022, 20(8): 1376-1379. doi: 10.16766/j.cnki.issn.1674-4152.002601
GUAN J J, SHI P. Value evaluation of carotid atherosclerotic plaque ultrasound combined with blood lipid index in predicting cardiovascular disease[J]. Chinese Journal of General Practice, 2022, 20(8): 1376-1379. doi: 10.16766/j.cnki.issn.1674-4152.002601
|
[4] |
YAMAMOTO T, KAWADA K, OBAMA K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients[J]. Int J Mol Sci, 2021, 22(15): 8002. DOI: 10.3390/ijms22158002
|
[5] |
KARADENIZ F, KARADENIZ Y, ALTUNTAŞ E. Systemic immune-inflammation index, and neutrophilto-lymphocyte and platelet-to-lymphocyte ratios can predict clinical outcomes in patients with acute coronary syndrome[J]. Cardiovasc J Afr, 2023, 34: 1-7.
|
[6] |
陈忠, 杨耀国. 颈动脉狭窄诊治指南[J]. 中国血管外科杂志(电子版), 2017, 9(3): 169-175. doi: 10.3969/j.issn.1674-7429.2017.03.003
CHEN Z, YANG Y G. Guidelines for the diagnosis and treatment of carotid artery stenosis[J]. Chinese Journal of Vascular Surgery (Electronic Version), 2017, 9(3): 169-175. doi: 10.3969/j.issn.1674-7429.2017.03.003
|
[7] |
朱大龙. 中国2型糖尿病防治指南(2020年版)(上)[J]. 中国实用内科杂志, 2021, 41(8): 668-695.
ZHU D L. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part 1)[J]. Chinese Journal of Practical Internal Medicine, 2021, 41(8): 668-695.
|
[8] |
朱大龙. 中国2型糖尿病防治指南(2020年版)(下)[J]. 中国实用内科杂志, 2021, 41(9): 757-784.
ZHU D L. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part 2)[J]. Chinese Journal of Practical Internal Medicine, 2021, 41(9): 757-784.
|
[9] |
刘力生. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011, 19(8): 701-743.
LIU L S. Chinese guidelines for the prevention and treatment of hypertension 2010[J]. Chinese Journal of Hypertension, 2011, 19(8): 701-743.
|
[10] |
SONG P, FANG Z, WANG H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study[J]. Lancet Glob Health, 2020, 8(5): e721-e729.
|
[11] |
BÄCK M, YURDAGUL A J R, TABAS I, et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities[J]. Nat Rev Cardiol, 2019, 16(7): 389-406.
|
[12] |
FAN J, WATANABE T. Atherosclerosis: known and unknown[J]. Pathol Int, 2022, 72(3): 151-160. doi: 10.1111/pin.13202
|
[13] |
GAO S, XU L, ZHANG Y, et al. Salusin-α inhibits proliferation and migration of vascular smooth muscle cell via Akt/mTOR signaling[J]. Cell Physiol Biochem, 2018, 50(5): 1740-1753. doi: 10.1159/000494792
|
[14] |
ALONSO-HERRANZ L, ALBARRÁN-JUÁREZ J, BENTZON J F. Mechanisms of fibrous cap formation in atherosclerosis[J]. Front Cardiovasc Med, 2023, 10: 1254114. DOI: 10.3389/fcvm.2023.1254114
|
[15] |
LIU J, AO W, ZHOU J, et al. The correlation between PLR-NLR and prognosis in acute myocardial infarction[J]. Am J Transl Res, 2021, 13(5): 4892-4899.
|
[16] |
KONG P, CUI Z Y, HUANG X F, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention[J]. Signal Transduct Target Ther, 2022, 7(1): 131. doi: 10.1038/s41392-022-00955-7
|
[17] |
ROY P, ORECCHIONI M, LEY K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity[J]. Nat Rev Immunol, 2022, 22(4): 251-265. doi: 10.1038/s41577-021-00584-1
|
[18] |
ROCHETTE L, DOGON G, RIGAL E, et al. Interplay between efferocytosis and atherosclerosis[J]. Arch Cardiovasc Dis, 2023. DOI: 10.1016/j.acvd.2023.07.007.
|
[19] |
RHOADS J P, MAJOR A S. How oxidized low-density lipoprotein activates inflammatory responses[J]. Crit Rev Immunol, 2018, 38(4): 333-342. doi: 10.1615/CritRevImmunol.2018026483
|
[20] |
ZHENG Y, LI Y, RAN X, et al. Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway[J]. Cell Mol Life Sci, 2022, 79(6): 311. doi: 10.1007/s00018-022-04331-0
|
[21] |
TYRRELL D J, GOLDSTEIN D R. Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6[J]. Nat Rev Cardiol, 2021, 18(1): 58-68. doi: 10.1038/s41569-020-0431-7
|
[22] |
BUGGER H, ZIRLIK A. Anti-inflammatory strategies in atherosclerosis[J]. Hamostaseologie, 2021, 41(6): 433-442. doi: 10.1055/a-1661-0020
|
[23] |
RAGGI P, GENEST J, GILES J T, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions[J]. Atherosclerosis, 2018, 276: 98-108. doi: 10.1016/j.atherosclerosis.2018.07.014
|